2017
Telmisartan improves vascular remodeling through ameliorating prooxidant and profibrotic mechanisms in hypertension via the involvement of transforming growth factor-β1
Abstract: Vascular remodeling is a common complication and pathological basis of hypertension. Transforming growth factor-β1 (TGF-β1)/small mothers against decapentaplegic 3 (Smad3) is considered a potential therapeutic target for vascular remodeling in hypertension. The present study aimed to demonstrate the antifibrotic effects of telmisartan and examined the potential mechanisms associated with its prevention of vascular remodeling. Spontaneously hypertensive rats (SHRs) were treated with telmisartan (20 mg/kg), and …
Search citation statements
Paper Sections
Select...
14
5
5
2
Citation Types
3
15
0
0
Year Published
Range
2018
2026
Publication Types
Select...
24
Relationship
1
23
Authors
Journals
Cited by 24 publications
(18 citation statements)
References 37 publications
3
15
0
0
Abstract
Smart CitationsHow this paper cites the one you are viewing
“…Once the PI3K-AKT signaling pathway becomes active, the activation of various other related signaling pathways, which are involved in apoptosis, protein synthesis, metabolism, and cell cycle, can be accelerated [ 28 ]. Consistently, our study supports the assumption that DHHQD could alleviate RIF partly by targeting the PI3K-AKT signaling pathway as well as related signaling pathways, such as the NF- κ B and toll-like receptor signaling pathways [ 29 ].…”
Section: Results
supporting
confidence: 89%